Mirabilis Medical is the developer of a non-invasive therapeutic ultrasound platform with an initial application to the ablation of uterine fibroids. Symptomatic uterine fibroids affect approximately 25% of all women at some point in their lives, and can cause pain, abnormal bleeding, pregnancy loss, and infertility. The Mirabilis platform uses high resolution ultrasound imaging to localize ablation, and a proprietary ultrasound technology to quickly and non-invasively ablate tissue deep in the body. The company believes that this ablation modality has several other potential clinical applications. Kevin Fong Nelson Teng
Total raised: $1M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News

Mentions in press and media 2

15.04.2010Mirabilis ...Share Share on Facebook Share ...-Luke Timme...xconomy.co...
15.04.2010Mirabilis ...Share Share on Facebook Share ...-Luke Timme...xconomy.co...